SHOCKING: Epizyme | Mind Blowing Facts

Pharma Exec To Plead Guilty In Insider Trading Case: Report

Dishant Gupta allegedly used his wife's brokerage account to make more than $262,000 in illegal profits.

International Business Times · Sep 11, 2024

Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022

Upgrades

Benzinga · Jun 28, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022

Upgrades

Benzinga · Jun 27, 2022

Epizyme's Return On Capital Employed Insights

According to Benzinga Pro data, during Q4, Epizyme (NASDAQ:EPZM) posted sales of $11.58 million. Earnings were up 23.06%, but Epizyme still reported an overall loss of $50.65 million.

Benzinga · Mar 4, 2022

Recap: Epizyme Q4 Earnings

  Epizyme (NASDAQ:EPZM) reported its Q4 earnings results on Tuesday, March 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga · Mar 1, 2022

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Epizyme (NASDAQ:EPZM) shares increased by 7.3% to $1.32 during Tuesday's after-market session. Epizyme's trading volume hit 240.6K shares by close, accounting for 10.7% of its average volume over the last 100 days. The company's market cap stands at $140.0 million.

Benzinga · Feb 1, 2022

Epizyme Raises $85M Via Equity Issued At 21% Discount

Epizyme Inc (NASDAQ: EPZM) has priced its underwritten public offering of 56.7 million shares at 

Benzinga · Jan 27, 2022